Delhi HC set to rule on Vimal Elaichi maker’s challenge to Maharashtra FDA notices

The Delhi High Court is due to decide whether it can hear PB Agro LLP’s plea to quash Maharashtra FDA show-cause notices alleging that Vimal Elaichi celebrity advertising surrogate-promotes banned Vimal Pan Masala.

— Source publishedMon, 14 Sept, 2026, 09:37 IST·First seen Mon, 14 Sept, 2026, 10:41 IST·Source ET Brand Equity

What happened

Delhi High Court will rule on jurisdiction over Vimal Elaichi maker PB Agro’s challenge to Maharashtra FDA notices alleging its celebrity ads surrogate-promote

Key facts

  • August 11, 2026
  • September 14
  • 2001
  • 2013

What changed

Delhi High Court will rule on jurisdiction over Vimal Elaichi maker PB Agro’s challenge to Maharashtra FDA notices alleging its celebrity ads surrogate-promote banned Vimal Pan Masala.

Why this matters

Delhi HC’s jurisdiction ruling is a near-term compliance watchpoint for FMCG brands using celebrity-led extensions that could be deemed surrogate advertising for banned products.

What to watch

  • Whether the Delhi High Court rules on territorial jurisdiction, grants interim protection, or addresses the merits of surrogate promotion.
  • The exact wording of the Maharashtra FDA notices, including cited provisions, requested corrective actions, and any proposed penalties.
  • Whether the ruling distinguishes Vimal Elaichi as a standalone FMCG product from the banned pan masala brand.
  • Any escalation from a show-cause notice to advertising withdrawal orders, product-sale restrictions, prosecution, or penalties.
  • Responses from ASCI, the Ministry of Information and Broadcasting, FSSAI, and other state FDAs.

Also reported by